Loading...

PE/Cyanine7 anti-mouse CD38 Antibody

Pricing & Availability
Clone
90 (See other available formats)
Regulatory Status
RUO
Other Names
T10
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
90_PECy7_011108
C57BL/6 mouse splenocytes stained with 90 PE/Cyanine7
  • 90_PECy7_011108
    C57BL/6 mouse splenocytes stained with 90 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
102717 25 µg 85€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102718 100 µg 259€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD38 is a 45 kD type II transmembrane glycoprotein also known as T10. It is an ADP-ribosyl hydrolase expressed at variable levels on hematopoietic cells and in some non-hematopoietic tissues (such as brain, muscle, and kidney). In humans, it is expressed at high levels on plasma cells and activated T and B cells, natural killer (NK) lymphocytes, myeloblasts, and erythroblasts. By functioning as both a cyclase and a hydrolase, CD38 mediates lymphocyte activation, adhesion, and the metabolism of cADPR and NAADP. CD31 is the ligand of CD38.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse bone marrow pre-B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Product Citations
  1. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  2. Jiang W, et al. 2021. Sci Rep. 11:1864. PubMed
  3. D'Avola A, et al. 2022. J Clin Invest. 132: . PubMed
  4. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  5. Hu Q, et al. 2022. Cell Rep. 40:111035. PubMed
  6. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  7. Voss LF, et al. 2023. Front Immunol. 13:1021370. PubMed
  8. Fontana MF, et al. 2023. Elife. 12: . PubMed
  9. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  10. Zaiken M, et al. 2022. Blood. 139:2983. PubMed
  11. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  12. Ludwig J, et al. 2023. NPJ Vaccines. 8:52. PubMed
  13. Yazicioglu YF, et al. 2023. Nat Immunol. 24:991. PubMed
  14. Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
  15. Shi B, et al. 2018. J Immunol. 200:586. PubMed
  16. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  17. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  18. Kim CC et al. 2019. Cell Rep. 27(5):1446-1460 . PubMed
  19. Jia X, et al. 2021. Clin Transl Immunology. 10:e1336. PubMed
  20. Juul-Madsen K, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  21. Ly A, et al. 2020. Cell Reports. 29(8):2257-2269.e6.. PubMed
  22. Muppidi J, et al. 2015. J Exp Med. 212: 2213 - 2222. PubMed
  23. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  24. Duan L, et al. 2021. Immunity. 54:2256. PubMed
  25. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  26. Mintz MA, et al. 2019. Immunity. 51:310. PubMed
  27. Ise W, et al. 2018. Immunity. 48:702. PubMed
  28. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  29. Abbott RK, et al. 2018. Immunity. 48:133. PubMed
  30. Hilpert C, et al. 2019. J Immunol. 203:3068. PubMed
  31. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  32. Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed
  33. Riedel R, et al. 2020. Nat Commun. 11:2570. PubMed
  34. Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
  35. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  36. Kajikawa A, et al. 2015. PLoS One. 10: e0141713. PubMed
  37. Teo TH, et al. 2018. Nat Commun. 9:3905. PubMed
  38. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  39. Andersen TK, et al. 2021. Front Immunol. 12:747032. PubMed
  40. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  41. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  42. Singh KS, et al. 2020. Nat Commun. 0.786805556. PubMed
  43. Kaji T, et al. 2012. J Exp Med. 209:2079. PubMed
  44. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  45. Smith LK, et al. 2021. Elife. 10:. PubMed
  46. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  47. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  48. Ryg-Cornejo V, et al. 2016. Cell Rep. 14:68-81. PubMed
  49. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  50. Zhang B, et al. 2021. Nature. 599:471. PubMed
  51. Yu M, et al. 2012. Proc Natl Acad Sci U S A. 109:E879. PubMed
  52. Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
  53. Trindade BC, et al. 2021. Immunity. 54:2273. PubMed
  54. Song W, et al. 2022. Immunity. 55:290. PubMed
  55. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  56. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
RRID
AB_2072892 (BioLegend Cat. No. 102717)
AB_2275531 (BioLegend Cat. No. 102718)

Antigen Details

Structure
ADP-ribosyl hydrolase, 42 kD
Distribution

B cells, NK cells, T cell subset, brain, muscle, kidney

Function
Regulation of cellular activation/proliferation, adhesion, metabolism of cADPR and NAADP
Ligand/Receptor
CD31, hyaluronic acid
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Shubinsky G, et al. 1997. Immunity 7:315.
3. Cesano A, et al. 1998. J. Immunol. 160:1106.
4. Cockayne DA, et al. 1998. Blood 92:1324.

Gene ID
12494 View all products for this Gene ID
UniProt
View information about CD38 on UniProt.org
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account